[en] The Societe Francaise des Sciences et Techniques Pharmaceutiques (SFSTP) published in 1997 a guide on the validation of chromatographic bio-analytical methods, which introduces new concepts in three different areas: stages of the validation, test of acceptability of a method and design of experiments to perform. In 'stages of validation', the SFSTP guide requires two phases to validate a method. The first phase, called 'prevalidation', is intended to (1) identify the model to use for the calibration curve; (2) evaluate the limits of quantitation; and (3) provide good estimates of the precision and bias of the method before designing the 'validation' phase per se. In the 'test of acceptability', the use of the interval hypotheses is envisaged by the SFSTP guide, not on the parameters of bias and precision, but on individual results by mixing mean bias and intermediate precision in a single test. The SFSTP guide also avoids the use of Satterthwaite's df for testing the acceptability. The reasons for those choices are discussed extensively. In 'design of experiments', much effort has been devoted to improving the quality of results by optimally designing and sizing the experiments to perform in validation. The rationale for using near D-optimal designs for the calibration curve is demonstrated and sample sizes are proposed to correctly size the validation experiments. (C) 2003 Elsevier Science B.V. All rights reserved.
Disciplines :
Pharmacy, pharmacology & toxicology Chemistry
Author, co-author :
Boulanger, Bruno ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Chiap, Patrice ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Dewé, Walthère ; Université de Liège - ULiège > Analyse des médicaments
Crommen, Jacques ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Smith, W.C., Sittampalam, G.S., (1998) J. Biopharm. Statistics, 8, pp. 509-532
Kringle, R.O., (1994) Pharm. Res., 11, pp. 556-560
Kringle, R., Khan-Malek, R., Statistical intervals for nested random samples in assay validation (1994) Midwest Biopharmaceutical Statistics Workshop, , Muncie, IN, May 24
Hartmann, C., Smeyers-Verbeke, J., Pennick W. XX, Van der Heyden, Y., Vankeerberghen, P., Massart, D.L., (1995) Anal. Chem., 67, pp. 4491-4499
Schuirmann, D.J., (1987) J. Pharmacokin. Biopharm., 15, pp. 657-680
Hartmann, C., Massart, D.L., McDowall, R.D., (1994) J. Pharm. Biomed. Anal., 12, pp. 1337-1343
Rocke, D.M., Jones, G., (1997) Technometrics, 39, pp. 162-170
(1989), Explanatory Note EEC III/844/87 EN-Final, August
Chow, S.-C., Liu, J.-P., Statistical design and analysis in pharmaceutical sciences: Validation, process controls and stability (1995) Statistics Textbooks and Monographs, 143. , New York: Marcel Dekker